| [1] | Picozzi K, Carrington M, Welburn SC (2008) A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense. Exp Parasitol 118: 41–46. doi: 10.1016/j.exppara.2007.05.014
|
| [2] | Radwanska M, Claes F, Magez S, Magnus E, Perez-Morga D, et al. (2002) Novel primer sequences for polymerase chain reaction-based detection of Trypanosoma brucei gambiense. Am J Trop Med Hyg 67: 289–295.
|
| [3] | Picozzi K, Fèvre EM, Odiit M, Carrington M, Eisler M, et al. (2005) Sleeping sickness in Uganda: a thin line between two fatal diseases. BMJ 331: 1238–1241. doi: 10.1136/bmj.331.7527.1238
|
| [4] | Gooding RH, Krafsur ES (2004) Tsetse genetics: applications to biology and systematics. In: Maudlin I, Holmes PH, Miles MA, editors. The trypanosomiases. Wallingford: CABI. pp. 95–111.
|
| [5] | Onyango RJ, van Hoeve K, de Raadt P (1966) The epidemiology of Trypanosoma rhodesiense sleeping sickness in Alego location, central Nyanza, Kenya. I. Evidence that cattle may act as reservoir hosts of trypanosomes infective to man. Trans R Soc Trop Med Hyg 60: 175–182. doi: 10.1016/0035-9203(66)90024-1
|
| [6] | Heisch RB, McMahon JP, Manson-Bahr PEC (1958) The isolation of Trypanosoma rhodesiense from a bushbuck. BMJ 14: 1203–1204. doi: 10.1136/bmj.2.5106.1203
|
| [7] | Geigy R, Mwambu PM, Kauffmann M (1971) Sleeping sickness survey in Musoma District, Tanzania. IV. Examination of wild mammals as a potential reservoir for T. rhodesiense. Acta Trop 18: 221–230.
|
| [8] | Hide G, Tait A, Maudlin I, Welburn SC (1996) The origins, dynamics and generation of Trypanosoma brucei rhodesiense epidemics in East Africa. Parasitol Today 12: 50–55. doi: 10.1016/0169-4758(96)80654-5
|
| [9] | Fèvre EM, Coleman PG, Odiit M, Magona JW, Welburn SC, et al. (2001) The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda. Lancet 358: 625–628. doi: 10.1016/S0140-6736(01)05778-6
|
| [10] | Simo G, Asonganyi T, Nkinin SW, Njiokou F, Herder S (2006) High prevalence of Trypanosoma brucei gambiense group 1 in pigs from the Fontem sleeping sickness focus in Cameroon. Vet Parasitol 139: 57–66. doi: 10.1016/j.vetpar.2006.02.026
|
| [11] | Mehlitz D, Zillmann U, Scott CM, Godfrey DG (1982) Epidemiological studies in the animal reservoir of gambiense sleeping sickness. Part III. Characterization of Trypanozoon stocks by isoenzymes and sensitivity to human serum. Tropenmed Parasitol 33: 113–118.
|
| [12] | Pépin J, Méda HA (2001) The epidemiology and control of human African trypanosomiasis. Adv Parasitol 49: 71–132. doi: 10.1016/s0065-308x(01)49038-5
|
| [13] | Louis FJ, Simarro PP, Lucas P (2002) Maladie du sommeil: cent ans d'évolution des strategies de lutte. Bull Soc Pathol Exot 95: 331–336.
|
| [14] | Welburn SC, Fèvre EM, Coleman PG, Odiit M, Maudlin I (2001) Sleeping sickness: a tale of two diseases. Trends Parasitol 17: 19–24. doi: 10.1016/S1471-4922(00)01839-0
|
| [15] | Haydon DT, Cleaveland S, Taylor LH, Laurenson MK (2002) Identifying reservoirs of infection: a conceptual and practical challenge. Emerg Infect Dis 8: 1468–1473. doi: 10.3201/eid0812.010317
|
| [16] | Ebeja AK, Lutumba P, Molisho D, Kegels G, Miaka mia Bilenge C, et al. (2003) La maladie de sommeil dans la région Ville de Kinshasa: une analyse rétrospective des données de surveillance sur la période 1996–2000. Trop Med Int Health 8: 949–955. doi: 10.1046/j.1365-3156.2003.01116.x
|
| [17] | Odiit M, Shaw A, Welburn SC, Fèvre EM, Coleman PG, et al. (2004) Assessing the patterns of health-seeking behaviour and awareness among sleeping-sickness patients in eastern Uganda. Ann Trop Med Parasitol 98: 339–348. doi: 10.1179/000349804225003389
|
| [18] | Gouteux JP, Bansimba P, Noireau F, Frezil JL (1987) Le co？ t du traitement individuel de la trypanosomiase à T. b. gambiense dans le foyer du Niari (Congo). Med Trop (Mars) 47: 61–63.
|
| [19] | Abel PM, Kiala G, Loa V, Behrend M, Musolf J, et al. (2004) Retaking sleeping sickness control in Angola. Trop Med Int Health 9: 141–148. doi: 10.1046/j.1365-3156.2003.01152.x
|
| [20] | Engels D, Savioli L (2006) Reconsidering the underestimated burden caused by neglected tropical diseases. Trends Parisatol 22: 363–366. doi: 10.1016/j.pt.2006.06.004
|
| [21] | Jannin J, Simarro PP, Louis FJ (2003) Le concept de maladie negligée. Med Trop (Mars) 63: 219–221.
|
| [22] | World Health Organization (1998) Control and surveillance of African trypanosomiasis. Geneva: WHO.
|
| [23] | Simarro PP, Jannin J, Cattand P (2008) Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med 5: e55. doi:10.1371/journal.pmed.0050055. doi: 10.1371/journal.pmed.0050055
|
| [24] | World Health Organization (2006) Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly Epidemiol Rec 81: 71–80.
|
| [25] | Shaw AP, Cattand P (2001) Analytical tools for planning cost-effective surveillance in Gambiense sleeping sickness. Med Trop (Mars) 61: 412–421.
|
| [26] | World Bank (1993) World development report 1993: Investing in health. New York: Oxford University Press.
|
| [27] | Murray CJL, Lopez AD (1996) The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press.
|
| [28] | Murray CJL, Lopez AD (1996) Global health statistics: a compendium of incidence, prevalence and mortality estimates for over 200 conditions. Cambridge: Harvard University Press.
|
| [29] | World Health Organization (2008) Global Burden of Disease. Available: http://www.who.int/healthinfo/global_bur？den_disease/en/index.html. Accessed 30 November 2008.
|
| [30] | World Health Organization (2003) The world health report 2003. Shaping the future. Geneva: WHO.
|
| [31] | Mathers CD, Ezzati M, Lopez AD (2007) Measuring the burden of neglected tropical diseases: the Global Burden of Disease framework. PLoS Negl Trop Dis 1: e114. doi:10.1371/journal.pntd.0000114. doi: 10.1371/journal.pntd.0000114
|
| [32] | Murray CJL, Lopez AD (1996) Evidence-based health policy–lessons from the Global Burden of Disease study. Science 274: 740–743. doi: 10.1126/science.274.5288.740
|
| [33] | Sassi F (2006) Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan 21: 402–408. doi: 10.1093/heapol/czl018
|
| [34] | Gold MR, Stevenson D, Fryback DG (2002) HALYS and QALYS and DALYS, oh my: similarities and differences in summary measures of population health. Ann Rev Public Health 23: 115–134. doi: 10.1146/annurev.publhealth.23.100901.140513
|
| [35] | Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442. doi:10.1371/journal.pmed.0030442. doi: 10.1371/journal.pmed.0030442
|
| [36] | Stein CTK, Hendrickx S, Prüss-Ustün A, Wolfson L, et al. (2007) The global burden of disease assessments–WHO is responsible? PLoS Negl Trop Dis e161. doi:10.1371/journal.pntd.0000161. doi: 10.1371/journal.pntd.0000161
|
| [37] | Murray CJL, Lopez AD, Wibulpolprasert S (2004) Monitoring global health: time for new solutions. BMJ 329: 1096–1100. doi: 10.1136/bmj.329.7474.1096
|
| [38] | Ashford RW (2000) The leishmaniases as emerging and reemerging zoonoses. Int J Parasitol 30: 1269–1281. doi: 10.1016/S0020-7519(00)00136-3
|
| [39] | Pawlowski ZS (2008) Control of neurocysticercosis by routine medical and veterinary services. Trans R Soc Trop Med Hyg 102: 228–232. doi: 10.1016/j.trstmh.2007.10.007
|
| [40] | Bossert TJ, Beauvais JC (2002) Decentralization of health systems in Ghana, Zambia, Uganda and the Philippines: a comparative analysis of decision space. Health Policy Plan 17: 14–31. doi: 10.1093/heapol/17.1.14
|
| [41] | Jeppsson A (2001) Financial priorities under decentralization in Uganda. Health Policy Plan 16: 187–192. doi: 10.1093/heapol/16.2.187
|
| [42] | Kapiriri L, Norheim OF, Heggenhougen K (2003) Using burden of disease information for health planning in developing countries: experiences from Uganda. Soc Sci Med 56: 2433–2441. doi: 10.1016/S0277-9536(02)00246-0
|
| [43] | Jeppsson A, Okuonzi SA, Ostergren P-O, Hagstrom B (2004) Using burden of disease/cost-effectiveness as an instrument for district health planning: experiences from Uganda. Health Policy 70: 261–270. doi: 10.1016/j.healthpol.2004.02.009
|
| [44] | Fèvre EM, Odiit M, Coleman PG, Welburn SC, Woolhouse MEJ (2008) Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda. BMC Public Health 8: 96. doi: 10.1186/1471-2458-8-96
|
| [45] | Monath TP (2006) Yellow fever as an endemic/epidemic disease and priorities for vaccination. Bull Soc Pathol Exot 99: 341–347.
|
| [46] | Zuckerman JN, Rombo L, Fisch A (2007) The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis 7: 521–530. doi: 10.1016/S1473-3099(07)70138-X
|
| [47] | Worrall E, Rietveld A, Delacollette C (2004) The burden of malaria epidemics and cost-effectiveness of interventions in epidemic situations in Africa. Am J Trop Med Hyg 71: 136–140.
|
| [48] | Vega JC, Sanchez BF, Montero LM, Montana R, del Pilar Mahecha M, et al. (2007) The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004. Trop Med Int Health 12: 1540–1544. doi: 10.1111/j.1365-3156.2007.01962.x
|
| [49] | Van Nieuwenhove S, Betu-Ku-Mesu VK, Diabakana PM, Declercq L, Bilenge CMM (2001) Sleeping sickness resurgence in the DRC: the past decade. Trop Med Int Health 6: 335–341. doi: 10.1046/j.1365-3156.2001.00731.x
|
| [50] | Lutumba P, Robays J, Miaka mia Bilenge C, Kande Betu Ku Mesu V, Molisho D, et al. (2005) Trypanosomiasis control, Democratic Republic of Congo, 1993–2003. Emerg Infect Dis 11: 1382–1388. doi: 10.3201/eid1109.041020
|
| [51] | Fox-Rushby JA, Hanson K (2001) Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan 16: 326–331. doi: 10.1093/heapol/16.3.326
|
| [52] | Hyder AA, Morrow RH (2006) Measures of health and disease in populations. In: Merson MH, Black RE, Mills A, editors. International public health: diseases, programs, systems, and policies. 2nd edition. Sudbury (Massachusetts): Jones and Bartlett. pp. 1–42.
|
| [53] | Murray CJL (1994) Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 72: 429–445.
|
| [54] | Paalman M, Bekedam H, Hawken L, Nyheim D (1998) A critical review of priority setting in the health sector: the methodology of the 1993 World Development Report. Health Policy Plan 13: 13–31. doi: 10.1093/heapol/13.1.13
|
| [55] | Goodman CA, Coleman PG, Mills AJ (1999) Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 354: 378–385. doi: 10.1016/S0140-6736(99)02141-8
|
| [56] | Ad Hoc Committee on Health Research Relating to Future Intervention Options (1996) Investing in health research and development. Geneva: WHO.
|
| [57] | Politi C, Carrin G, Evans D, Kuzoe FAS, Cattand PD (1995) Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda. Health Econ 4: 273–287. doi: 10.1002/hec.4730040404
|
| [58] | Stanghellini A, Josenando T (2001) The situation of sleeping sickness in Angola: a calamity. Trop Med Int Health 6: 330–334. doi: 10.1046/j.1365-3156.2001.00724.x
|
| [59] | Robays J, Bilengue MM, Van der Stuyft P, Boelaert M (2004) The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Trop Med Int Health 9: 542–550. doi: 10.1111/j.1365-3156.2004.01240.x
|
| [60] | Laveissière C, Meda AH, Doua F, Sane B (1998) Dépistage de la maladie du sommeil: efficacité comparée des équipes mobiles et des agents de santé communautaires. Bull World Health Organ 76: 559–564.
|
| [61] | Lutumba P, Makieya E, Shaw A, Meheus F, Boelaert M (2007) Human African trypanosomiasis in a rural community, Democratic Republic of Congo. Emerg Infect Dis 13: 248–254. doi: 10.3201/eid1302.060075
|
| [62] | Kristjanson PM, Swallow BM, Rowlands GJ, Kruska RL, de Leeuw PN (1999) Measuring the costs of African animal trypanosomosis, the potential benefits of control and returns to research. Agricultural Systems 59: 79–98. doi: 10.1016/s0308-521x(98)00086-9
|
| [63] | Swallow BM (2000) Impacts of trypanosomiasis on African agriculture. Rome: PAAT Technical and Scientific Series 2.
|
| [64] | Budd LT (1999) DFID-funded tsetse and trypanosomiasis research and development since 1980: economic analysis. Edinburgh: DFID.
|
| [65] | World Health Organization (2006) The control of neglected zoonotic diseases: a route to poverty alleviation. Geneva: WHO.
|
| [66] | Kabasa JD (2007) Public-private partnership works to stamp out sleeping sickness in Uganda. Trends Parisatol 23: 191–192. doi: 10.1016/j.pt.2007.03.006
|
| [67] | Mathers CD, Lopez AD, Murray CJL (2006) The burden of disease and mortality by condition: Data, methods and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global burden of disease and risk factors. New York: Oxford University Press. pp. 45–240.
|
| [68] | World Health Organization (2003) Global Burden of Disease (GBD) study 2000–2002: GBD sequelae and case definitions. Available: http://www.who.int/healthinfo/statistics？/gbdestimatescasedefinitions.pdf. Accessed 30 November 2008.
|
| [69] | Fèvre EM, Coleman PG, Welburn SC, Maudlin I (2004) Reanalyzing the 1900–1920 sleeping sickness epidemic in Uganda. Emerg Infect Dis 10: 567–573. doi: 10.3201/eid1004.020626
|
| [70] | Chisi JE, Misiri H, Zverev Y, Nkhoma A, Sternberg JM (2004) Anaemia in human African trypanosomiasis caused by Trypanosoma brucei rhodesiense. East Afr Med J 81: 505–508. doi: 10.4314/eamj.v81i10.9232
|
| [71] | Kennedy PGE (2006) Diagnostic and neuropathogenesis issues in human African trypanosomiasis. Int J Parasitol 36: 505–512. doi: 10.1016/j.ijpara.2006.01.012
|
| [72] | Apted FIC (1970) Clinical manifestations and diagnosis of sleeping sickness. In: Mulligan HW, Potts WH, Kershaw WE, editors. The African trypanosomiases. London: George Allen and Unwin. pp. 661–683.
|
| [73] | Blum JA, Burri C, Hatz C, Kazumba L, Mangoni P, et al. (2007) Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis). Trop Med Int Health 12: 1422–1432. doi: 10.1111/j.1365-3156.2007.01948.x
|
| [74] | Ginoux C, Frezil JL, Alary JC (1982) Symptoms of human trypanosomiasis at the first diagnostic phase in the People Republic of Congo (author's translation). Med Trop (Mars) 42: 281–287.
|
| [75] | Boa YF, Traore MA, Doua F, Kouassi-Traore MT, Kouassi BE, et al. (1988) Les différents tableaux cliniques actuels de la trypanosomiase humaine africaine a T. b. gambiense. Analyse de 300 dossiers du foyer de Daloa, Cote d'Ivoire. Bull Soc Pathol Exot 81: 427–444.
|
| [76] | Blum J, Schmid C, Burri C (2006) Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta Trop 97: 55–64. doi: 10.1016/j.actatropica.2005.08.001
|
| [77] | Kennedy PGE (2008) Diagnosing central nervous system trypanosomiasis: two stage or not to stage? Trans R Soc Trop Med Hyg 102: 306–307. doi: 10.1016/j.trstmh.2007.11.011
|
| [78] | Braakman HMH, van de Molengraft FJJM, Hubert WWA, Boerman DH (2006) Lethal African trypanosomiasis in a traveler: MRI and neuropathology. Neurology 66: 1094–1096. doi: 10.1212/01.wnl.0000209306.41647.13
|
| [79] | Fairlamb AH (2003) Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parisatol 19: 488–494. doi: 10.1016/j.pt.2003.09.002
|
| [80] | Jannin J, Cattand P (2004) Treatment and control of human African trypanosomiasis. Curr Opin Infect Dis 17: 565–571. doi: 10.1097/00001432-200412000-00009
|
| [81] | Knobel DL, Cleaveland S, Coleman PG, Fèvre EM, Meltzer MI, et al. (2005) Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 85: 360–368. doi: /S0042-96862005000500012
|
| [82] | Aroke AH, Asonganyi T, Mbonda E (1998) Influence of a past history of Gambian sleeping sickness on physical growth, sexual maturity and academic performance of children in Fontem, Cameroon. Ann Trop Med Parasitol 92: 829–835. doi: 10.1080/00034989858862
|
| [83] | Cramet R (1982) La maladie du sommeil chez l'enfant et ses sequelles a distance. A propos de 110 observations personnelles a l'hopital de Fontem (Cameroun). Med Trop (Mars) 42: 27–31.
|
| [84] | Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD (2005) Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ 83: 171–177. doi: /S0042-96862005000300009
|
| [85] | Odiit M, Coleman PG, Liu W-C, McDermott J, Fèvre EM, et al. (2005) Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness cases. Trop Med Int Health 10: 840–849. doi: 10.1111/j.1365-3156.2005.01470.x
|
| [86] | Fèvre EM, Picozzi K, Fyfe J, Waiswa C, Odiit M, et al. (2005) A burgeoning epidemic of sleeping sickness in Uganda. Lancet 366: 745–747. doi: 10.1016/S0140-6736(05)67179-6
|
| [87] | Singh SP, Reddy DCS, Rai M, Sundar S (2006) Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop Med Int Health 11: 899–905. doi: 10.1111/j.1365-3156.2006.01647.x
|
| [88] | Fèvre EM, Kaboyo RW, Persson V, Edelsten M, Coleman PG, et al. (2005) The epidemiology of animal bite injuries in Uganda and projections of the burden of rabies. Trop Med Int Health 10: 790–798. doi: 10.1111/j.1365-3156.2005.01447.x
|
| [89] | Kinung'hi SM, Malele II, Kibona SN, Matemba LE, Sahani JK, et al. (2006) Knowledge, attitudes and practices on tsetse and sleeping sickness among communities living in and around Serengeti National Park, Tanzania. Tanzan Health Res Bull 8: 168–172. doi: 10.4314/thrb.v8i3.45115
|
| [90] | Arnesen T, Nord E (1999) The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ 319: 1423–1425. doi: 10.1136/bmj.319.7222.1423
|
| [91] | Musgrove P (2000) A critical review of ‘A critical review’: the methodology of the 1993 World Development Report, ‘Investing in Health’. Health Policy Plan 15: 110–115. doi: 10.1093/heapol/15.1.110
|
| [92] | King CH, Bertino A-M (2008) Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis 2: e209. doi:10.1371/journal.pntd.0000209. doi: 10.1371/journal.pntd.0000209
|
| [93] | Pullan R, Brooker S (2008) The health impact of polyparasitism in humans: are we under-estimating the burden of parasitic diseases? Parasitology 1: 12. doi: 10.1017/s0031182008000346
|
| [94] | Robays J, Raguenaud ME, Josenando T, Boelaert M (2008) Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola. Trop Med Int Health 13: 265–271. doi: 10.1111/j.1365-3156.2007.01999.x
|
| [95] | Zumla A (2002) Drugs for neglected diseases. Lancet Infect Dis 2: 393. doi: 10.1016/S1473-3099(02)00312-2
|
| [96] | Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, et al. (2002) Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet 359: 2188–2194. doi: 10.1016/S0140-6736(02)09096-7
|
| [97] | World Health Organization (2003) Global Burden of Disease (GBD) 2000: version 3 estimates. Available: http://www.who.int/healthinfo/global_bur？den_disease/estimates_regional_2000_v3/e？n/index.html. Accessed 2 December 2008.
|
